Outcomes that were significantly elevated during the 30 days after vaccination among subjects who only received DTaP-IPV/Hib (Group 1).Outcome description (HCUP code)SettingDoseRisk interval days 0–30Comparison interval days 31–60IRR (95% CI)Events (N)Rate/1000 person-monthsEvents (N)Rate/1000 person-monthsInfectious and parasitic diseases (1)Hospital250.3800.00NE (1.12, NE)Hypovolemia (3.8.2)Hospital170.5000.00NE (1.69, NE)Hypovolemia (3.8.2)HospitalAny 4a100.3120.074.70 (1.15, 31.57)Diseases of the respiratory system (8)Hospital1362.56151.182.17 (1.20, 4.08)Other lower respiratory disease (8.8)Hospital1120.8510.0810.86 (1.88, 234.21)Other and unspecified lower respiratory disease (8.8.3)Hospital1120.8510.0810.86 (1.88, 234.21)Diseases of the genitourinary system (10)ED460.9000.00NE (1.50, NE)Genitourinary symptoms and ill-defined conditions (10.1.8)EDAny 4a60.1900.00NE (1.45, NE)Genitourinary Image may be NSFW.
Clik here to view.
symptoms and ill-defined conditions (10.1.8)EDFirst 3b60.2500.00NE (1.44, NE)Diseases of the skin and subcutaneous tissue (12)ED4111.6530.463.57 (1.06, 15.95)Skin and subcutaneous tissue infections (12.1)ED460.9000.00NE (1.50, NE)Cardiac and circulatory congenital anomalies (14.1)Hospital260.4500.00NE (1.42, NE)Certain conditions originating in the perinatal BMS265246 (15)ED1191.3560.472.87 (1.18, 7.84)Certain conditions originating in the perinatal period (15)EDAny 4a160.5050.173.01 (1.14, 9.19)Other perinatal conditions (15.7)ED1191.3560.472.87 (1.18, 7.84)Other perinatal conditions (15.7)EDAny 4a160.5050.173.01 (1.14, 9.19)Other and unspecified perinatal conditions (15.7.4)ED1120.8530.243.62 (1.09, 15.99)Other and unspecified perinatal conditions (15.7.4)EDAny 4a100.3100.00NE (2.69, NE)Other and unspecified perinatal conditions (15.7.4)HospitalAny 4a50.1600.00NE (1.15, NE)Other and unspecified perinatal conditions (15.7.4)EDFirst 3b80.3300.00NE (2.05, NE)Injury and poisoning (16)Hospital280.6110.087.36 (1.18, 164.60)Injury and poisoning (16)Hospital450.7500.00NE (1.19, NE)Injury and poisoning (16)HospitalAny 4a180.5650.173.39 (1.31, 10.22)Fractures (16.2)HospitalAny 4a60.1900.00NE (1.45, NE)Fractures (16.2)HospitalFirst 3b50.2100.00NE (1.14, NE)Skull and face fractures (16.2.2)EDAny 4a50.1600.00NE (1.15, NE)Skull and face fractures (16.2.2)HospitalAny 4a50.1600.00NE (1.15, NE)Symptoms; signs; and ill-defined conditions and factors influencing health status (17)ED2896.76514.211.61 (1.14, 2.28)Symptoms; signs; and ill-defined conditions (17.1)ED2816.15413.381.82 (1.26, 2.67)Fever of unknown origin (17.1.2)ED2503.79252.061.84 (1.15, 3.02)Nausea and vomiting (17.1.6)ED1161.1450.392.89 (1.10, 8.83)ED = Emergency Department; NE = Not Evaluable; CI = Confidence Interval; IRR = Incidence Rate Ratio.a“Any 4” included post-vaccination outcomes combined across all doses wood a subject received (up to 4).b“First 3” refers to post-vaccination outcomes combined across the first 3 doses of DTaP-IPV/Hib.Full-size tableTable optionsView in workspaceDownload as CSV
Clik here to view.
